Published on in Vol 26 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/54518, first published
.
![Key Considerations for Designing Clinical Studies to Evaluate Digital Health Solutions Key Considerations for Designing Clinical Studies to Evaluate Digital Health Solutions](https://asset.jmir.pub/assets/f720aa5daa05a919e3bb3cd744cb8981.png 480w,https://asset.jmir.pub/assets/f720aa5daa05a919e3bb3cd744cb8981.png 960w,https://asset.jmir.pub/assets/f720aa5daa05a919e3bb3cd744cb8981.png 1920w,https://asset.jmir.pub/assets/f720aa5daa05a919e3bb3cd744cb8981.png 2500w)
1 Integrated Evidence Generation & Business Innovation, Bayer AG, Berlin, Germany
2 Integrated Evidence Generation & Business Innovation, Bayer HealthCare SAS, La Garenne Colombes, France
*all authors contributed equally